(Q45810735)

English

Miocamycin-containing triple therapy for H. pylori infection

scientific article published on 11 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

Miocamycin-containing triple therapy for H. pylori infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

Helicobacter pylori

1 reference

based on heuristic

inferred from title

author name string

Maria Pina Dore

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

Marco Massidda

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

Ozlem Yilmaz

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

Ebru Demiray-Gürbüz

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

Alessandra Manca

5

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

Gabrio Bassotti

6

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

publication date

11 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

18

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

285-289

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12048

21 January 2018

Review of macrolides and ketolides: focus on respiratory tract infections

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12048

21 January 2018

Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12048

21 January 2018

Detection of Helicobacter pylori and determination of clarithromycin susceptibility using formalin-fixed, paraffin-embedded gastric biopsy specimens by fluorescence in situ hybridization.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12048

21 January 2018

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12048

21 January 2018

Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12048

21 January 2018

Identifiers

10.1111/HEL.12048

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/23489645

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45810735&oldid=2083327524"